Open pelvic lymph node dissection for prostate cancer: a reassessment. (Q54003885)

23 May 2018

title

Open pelvic lymph node dissection for prostate cancer: a reassessment. (English)

1 reference

23 May 2018

0 references

1 reference

Campbell SC

1

1 reference

23 May 2018

Klein EA

series ordinal

2

1 reference

23 May 2018

Levin HS

series ordinal

3

1 reference

23 May 2018

Piedmonte MR

series ordinal

4

1 reference

23 May 2018

language of work or name

English

0 references

publication date

1 September 1995

1 reference

23 May 2018

published in

Urology

1 reference

23 May 2018

volume

46

1 reference

23 May 2018

issue

3

1 reference

23 May 2018

page(s)

352-355

1 reference

23 May 2018

The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980219-2

7 January 2021

Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980219-2

7 January 2021

The contemporary incidence of lymph node metastases in prostate cancer: implications for laparoscopic lymph node dissection

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980219-2

7 January 2021

Staging pelvic lymphadenectomy for carcinoma of the prostate risk versus benefit

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980219-2

7 January 2021

Intraoperative and early complications of staging pelvic lymph node dissection in prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980219-2

7 January 2021

Ability of preoperative serum prostate-specific antigen value to predict pathologic stage and DNA ploidy. Influence of clinical stage and tumor grade

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980219-2

7 January 2021

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980219-2

7 January 2021

Utility of preoperative serumprostate-specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980219-2

7 January 2021

Early hospital discharge after radical retropubic prostatectomy: impact on cost and complication rate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980219-2

7 January 2021

Prognostic significance of lymph nodal metastases in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980219-2

7 January 2021

Morbidity from pelvic lymphadenectomy in staging carcinoma of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980219-2

7 January 2021

Pelvic lymphadenectomy for staging clinically localized prostate cancer. Indications, complications, and results in 217 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980219-2

7 January 2021

Perioperative and postoperative complications from bilateral pelvic lymphadenectomy and radical retropubic prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980219-2

7 January 2021

Complications of laparoscopic pelvic lymph node dissection.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980219-2

7 January 2021

Frozen section detection of lymph node metastases in prostatic carcinoma: accuracy in grossly uninvolved pelvic lymphadenectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980219-2

7 January 2021

Accuracy of frozen section detection of lymph node metastases in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980219-2

7 January 2021

10.1016/S0090-4295(99)80219-2

Identifiers

DOI

1 reference

23 May 2018

1 reference

23 May 2018